Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018221291) PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPERACTIVE BLADDER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/221291 International Application No.: PCT/JP2018/019482
Publication Date: 06.12.2018 International Filing Date: 21.05.2018
IPC:
A61K 31/197 (2006.01) ,A61K 31/295 (2006.01) ,A61P 7/12 (2006.01) ,A61P 13/10 (2006.01) ,A61P 43/00 (2006.01)
[IPC code unknown for A61K 31/197][IPC code unknown for A61K 31/295][IPC code unknown for A61P 7/12][IPC code unknown for A61P 13/10][IPC code unknown for A61P 43]
Applicants:
SBIファーマ株式会社 SBI PHARMACEUTICALS CO., LTD. [JP/JP]; 東京都港区六本木一丁目6番1号 6-1, Roppongi 1-chome, Minato-ku, Tokyo 1066020, JP
国立大学法人高知大学 NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY [JP/JP]; 高知県高知市曙町二丁目5番1号 5-1, Akebono-cho 2-chome, Kochi-shi, Kochi 7808520, JP
Inventors:
田中 徹 TANAKA, Tohru; JP
高橋 究 TAKAHASHI, Kiwamu; JP
井上 啓史 INOUE, Keiji; JP
齋藤 源顕 SAITO, Motoaki; JP
津田 雅之 TSUDA, Masayuki; JP
福原 秀雄 FUKUHARA, Hideo; JP
久野 貴平 KUNO, Takahira; JP
清水 翔吾 SHIMIZU Shogo; JP
Agent:
南条 雅裕 NANJO, Masahiro; JP
瀬田 あや子 SETA, Ayako; JP
原 秀貢人 HARA, Hokuto; JP
伊波 興一朗 IHA, Koichiro; JP
Priority Data:
2017-10736731.05.2017JP
Title (EN) PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPERACTIVE BLADDER
(FR) AGENT PROPHYLACTIQUE OU THÉRAPEUTIQUE DESTINÉ À LA VESSIE HYPERACTIVE
(JA) 過活動膀胱の予防剤または治療剤
Abstract:
(EN) [Problem] Various side effects have been reported for conventional therapeutic drugs for hyperactive bladder, and a prophylactic or therapeutic agent for hyperactive bladder without causing side effects is desired. [Solution] Provided is a prophylactic or therapeutic agent for hyperactive bladder, said agent containing 5-aminolevulinic acids (ALA) as an active ingredient.
(FR) Le problème décrit par la présente invention concerne divers effets secondaires qui ont été rapportés pour des médicaments thérapeutiques classiques destinés à la vessie hyperactive, et un agent prophylactique ou thérapeutique destiné à la vessie hyperactive ne provoquant pas d'effets secondaires. La solution selon l’invention porte sur un agent prophylactique ou thérapeutique destiné à la vessie hyperactive, ledit agent contenant des acides 5-aminolévuliniques (ALA) comme principe actif.
(JA) 【課題】 既存の過活動膀胱の治療薬には、様々な副作用が報告されており、副作用のない過活動膀胱の予防剤または治療剤が切望されている。 【解決手段】 5-アミノレブリン酸(ALA)類を有効成分として含む、過活動膀胱の予防剤または治療剤を提供する。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)